Insights revealed by high-throughput genomic arrays in nonglial primary brain tumors

References

• Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO classification of tumours of the central nervous system. In: IARC WHO Classification of Tumours. WHO, Geneva, Switzerland (2007).
   Google Scholar
• Kieran MW, Walker D, Frappaz D, Prados M. Brain tumors: from childhood through adolescence into adulthood. J. Clin. Oncol.32, 4783–4789 (2010).
   Google Scholar
• Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P. Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors. J. Mol. Diagn.4, 433–443 (2006).
   Google Scholar
• Schröck E, Thiel G, Lozanova T et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol.6, 1203–1218 (1994).
   Google Scholar
• Shapiro JR, Yung WK, Shapiro WR. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res.6, 2349–2359 (1981).
   Google Scholar
• Smith JS, Perry A, Borell TJ et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol.3, 636–645 (2000).
   Google Scholar
• Idbaih A, Crinière E, Ligon KL, Delattre O, Delattre JY. Array-based genomics in glioma research. Brain Pathol.1, 28–38 (2010).
   Google Scholar
• Horbinski C, Miller CR, Perry A. Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade. Brain Pathol.1, 57–73 (2011).
   Google Scholar
• Pfister S, Janzarik WG, Remke M et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J. Clin. Invest.118, 1739–1749 (2008).
   PubMed Web of Science ®Google Scholar
• Jones DTW, Kocialkowski S, Liu L, Pearson DM, Ichimura K, Collins VP. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549: BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene20, 2119–2123 (2009).
   Google Scholar
• Sievert AJ, Jackson EM, Gai X et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol.3, 449–458 (2009).
   Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature7216, 1061–1068 (2008).
   Google Scholar
• Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol.12, 1045–1054 (2006).
   Google Scholar
• Ho DMT, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer5, 1538–1547 (2002).
   Google Scholar
• Gabeau-Lacet D, Engler D, Gupta S et al. Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J. Neuropathol. Exp. Neurol.10, 1155–1165 (2009).
   Google Scholar
• Dumanski JP, Carlbom E, Collins VP, Nordenskjöld M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc. Natl Acad. Sci. USA24, 9275–9279 (1987).
   Google Scholar
• Ruttledge MH, Sarrazin J, Rangaratnam S et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat. Genet.2, 180–184 (1994).
   Google Scholar
• Wellenreuther R, Kraus JA, Lenartz D et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am. J. Pathol.4, 827–832 (1995).
   Google Scholar
• Rouleau GA, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature6429, 515–521 (1993).
   Google Scholar
• Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell5, 791–800 (1993).
   Google Scholar
• Peyrard M, Fransson I, Xie YG et al. Characterization of a new member of the human β-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum. Mol. Genet.8, 1393–1399 (1994).
   Google Scholar
• Barski D, Wolter M, Reifenberger G, Riemenschneider MJ. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol.3, 623–631 (2010).
   Google Scholar
• Weber RG, Boström J, Wolter M et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc. Natl Acad. Sci. USA26, 14719–14724 (1997).
   Google Scholar
• Ketter R, Henn W, Niedermayer I et al. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J. Neurosurg.4, 601–607 (2001).
   Google Scholar
• Ketter R, Rahnenführer J, Henn W et al. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas. Neurosurgery1, 61–69 (2008).
   Google Scholar
• Pfisterer WK, Hank NC, Preul MC et al. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro. Oncol.4, 290–299 (2004).
   Google Scholar
• Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet. Cytogenet.2, 103–110 (1999).
   Google Scholar
• Carvalho LH, Smirnov I, Baia GS et al. Molecular signatures define two main classes of meningiomas. Mol. Cancer6, 64 (2007).
   Google Scholar
• Buckley PG, Jarbo C, Menzel U et al. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Cancer Res.7, 2653–2661 (2005).
   Google Scholar
• Shen Y, Nunes F, Stemmer-Rachamimov A et al. Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med. Genomics2, 42 (2009).
   Google Scholar
• Pérez-Magán E, Rodríguez de Lope A, Ribalta T et al. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro. Oncol.12, 1278–1290 (2010).
   PubMedGoogle Scholar
• DeLellis R, Lloyd R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs. In: IARC WHO Classification of Tumours. WHO, Geneva, Switzerland, 14–36 (2004).
   Google Scholar
• Ezzat S, Asa SL, Couldwell WT et al. The prevalence of pituitary adenomas: a systematic review. Cancer3, 613–619 (2004).
   Google Scholar
• Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab.6, 1427–1433 (1990).
   Google Scholar
• Trautmann K, Thakker RV, Ellison DW et al. Chromosomal aberrations in sporadic pituitary tumors. Int. J. Cancer6, 809–814 (2001).
   Google Scholar
• Hui AB, Pang JC, Ko CW, Ng HK. Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridization. Hum. Pathol.9, 1019–1023 (1999).
   Google Scholar
• Harada K, Nishizaki T, Ozaki S et al. Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization. Cancer Genet. Cytogenet.1, 38–41 (1999).
   Google Scholar
• Metzger AK, Mohapatra G, Minn YA et al. Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization. J. Neurosurg.2, 306–314 (1999).
   Google Scholar
• Rickert CH, Dockhorn-Dworniczak B, Busch G et al. Increased chromosomal imbalances in recurrent pituitary adenomas. Acta Neuropathol.6, 615–620 (2001).
   Google Scholar
• Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab.12, 4769–4775 (2006).
   Google Scholar
• Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet. J. Rare Dis.2, 18 (2007).
   PubMed Web of Science ®Google Scholar
• Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J. Neurosurg.4, 547–551 (1998).
   Google Scholar
• Rickert CH, Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J. Neurol. Neurosurg. Psychiatr.2, 260–261 (2003).
   Google Scholar
• Yoshimoto M, de Toledo SRC, da Silva NS et al. Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. J. Neurosurg.101(Suppl. 1), 85–90 (2004).
   Google Scholar
• Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch. Neurol.3, 291–297 (2010).
   Google Scholar
• Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist5, 526–539 (2009).
   Google Scholar
• Camilleri-Broët S, Martin A, Moreau A et al. Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d’étude des Leucénies et Autres Maladies du Sang (GOELAMS). Am. J. Clin. Pathol.5, 607–612 (1998).
   Google Scholar
• Swerdlow S, Campo E, Lee N et al. WHO classification of tumours of haematopoietic and lymphoid tissue. In: IARC WHO Classification of Tumours. WHO, Geneva, Switzerland, 236–237 (2008).
   Google Scholar
• Chen W, Houldsworth J, Olshen AB. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood6, 2477–2485 (2006).
   Google Scholar
• Beà S, Colomo L, López-Guillermo A et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J. Clin. Oncol.17, 3498–3506 (2004).
   Google Scholar
• Robledo C, García JL, Caballero D et al. Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. Cancer16, 3728–3737 (2009).
   Google Scholar
• Lin CH, Kuo KT, Chuang SS et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin. Cancer Res.4, 1152–1156 (2006).
   Google Scholar
• Braaten KM, Betensky PA, de Leval L et al. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin. Cancer Res.3, 1063–1069 (2003).
   Google Scholar
• Weber T, Weber RG, Kaulich K et al. Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol.1, 73–84 (2000).
   Google Scholar
• Harada K, Nishizaki T, Kubota H, Harada K, Suzuki M, Sasaki K. Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry. Cancer Genet. Cytogenet.2, 147–150 (2001).
   Google Scholar
• Schwindt H, Vater I, Kreuz M et al. Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma. Leukemia10, 1875–1884 (2009).
   Google Scholar
• Sung CO, Kim SC, Karnan S et al. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma. Blood4, 1291–1300 (2011).
   Google Scholar
• Cady FM, O’Neill BP, Law ME et al. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J. Clin. Oncol.29, 4814–4819 (2008).
   Google Scholar
• Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer1, 146–155 (2004).
   Google Scholar
• Jay V, Squire J, Becker LE, Humphreys R. Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis. Cancer11, 2862–2868 (1994).
   Google Scholar
• Pandita A, Balasubramaniam A, Perrin R, Shannon P, Guha A. Malignant and benign ganglioglioma: a pathological and molecular study. Neuro. Oncol.2, 124–134 (2007).
   Google Scholar
• Yin XL, Hui ABY, Pang JCS, Poon WS, Ng HK. Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genet. Cytogenet.1, 71–76 (2002).
   Google Scholar
• Hoischen A, Ehrler M, Fassunke J et al. Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH. Brain Pathol.3, 326–337 (2008).
   Google Scholar
• Suresh TN, Santosh V, Yasha TC et al. Medulloblastoma with extensive nodularity: a variant occurring in the very young – clinicopathological and immunohistochemical study of four cases. Childs Nerv. Syst.1, 55–60 (2004).
   Google Scholar
• Padovani L, Sunyach M, Perol D et al. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int. J. Radiat. Oncol. Biol. Phys.2, 433–440 (2007).
   Google Scholar
• Brandes AA, Franceschi E, Tosoni A et al. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit. Rev. Oncol. Hematol.2, 165–179 (2009).
   Google Scholar
• Bayani J, Zielenska M, Marrano P et al. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J. Neurosurg.3, 437–448 (2000).
   Google Scholar
• Hui ABY, Takano H, Lo K et al. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Clin. Cancer Res.13, 4707–4716 (2005).
   Google Scholar
• McCabe MG, Ichimura K, Liu L et al. High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors. J. Neuropathol. Exp. Neurol.6, 549–561 (2006).
   Google Scholar
• Michiels EMC, Weiss MM, Hoovers JMN et al. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J. Pediatr. Hematol. Oncol.3, 205–210 (2002).
   Google Scholar
• Pan E, Pellarin M, Holmes E et al. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin. Cancer Res.13, 4733–4740 (2005).
   Google Scholar
• Rossi MR, Conroy J, McQuaid D, Nowak NJ, Rutka JT, Cowell JK. Array CGH analysis of pediatric medulloblastomas. Genes Chromosomes Cancer3, 290–303 (2006).
   Google Scholar
• Remke M, Hielscher T, Northcott PA et al. Adult medulloblastoma comprises three major molecular variants. J. Clin. Oncol.19, 2717–2723 (2011).
   Google Scholar
• Korshunov A, Remke M, Werft W et al. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J. Clin. Oncol.18, 3054–3060 (2010).
   Google Scholar
• Mendrzyk F, Radlwimmer B, Joos S et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J. Clin. Oncol.34, 8853–8862 (2005).
   Google Scholar
• Pfister S, Remke M, Benner A et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J. Clin. Oncol.10, 1627–1636 (2009).
   Google Scholar
• Bjornsson J, Scheithauer BW, Okazaki H, Leech RW. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. J. Neuropathol. Exp. Neurol.1, 32–46 (1985).
   Google Scholar
• Hoffman HJ, Otsubo H, Hendrick EB et al. Intracranial germ-cell tumors in children. J. Neurosurg.4, 545–551 (1991).
   Google Scholar
• Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg.2, 155–167 (1985).
   Google Scholar
• Ho DM, Liu HC. Primary intracranial germ cell tumor. Pathologic study of 51 patients. Cancer6, 1577–1584 (1992).
   Google Scholar
• Matsutani M, Sano K, Takakura K et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J. Neurosurg.3, 446–455 (1997).
   Google Scholar
• Schneider DT, Calaminus G, Koch S et al. Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr. Blood Cancer2, 169–175 (2004).
   Google Scholar
• Calaminus G, Bamberg M, Baranzelli MC et al. Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics1, 26–32 (1994).
   Google Scholar
• Schneider DT, Zahn S, Sievers S et al. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod. Pathol.6, 864–873 (2006).
   Google Scholar
• Hassoun J, Gambarelli D, Grisoli F et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol.2, 151–156 (1982).
   Google Scholar
• Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW. Central neurocytoma: a review. J. Neurooncol.3, 377–384 (2004).
   Google Scholar
• Cerdá-Nicolás M, López-Ginés C, Peydro-Olaya A, Llombart-Bosch A. Central neurocytoma: a cytogenetic case study. Cancer Genet. Cytogenet.2, 173–174 (1993).
   Google Scholar
• Jay V, Edwards V, Hoving E et al. Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses. Case report. J. Neurosurg.2, 348–354 (1999).
   Google Scholar
• Yin XL, Pang JC, Hui AB, Ng HK. Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. J. Neurosurg.1, 77–81 (2000).
   Google Scholar
• Korshunov A, Sycheva R, Golanov A. Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance. Acta Neuropathol.3, 303–312 (2007).
   Google Scholar